DEPRECIATION, SHARE-BASED PAYMENTS, EMPLOYEE AND OTHER EXPENSES (Tables)

12 Months Ended

Dec. 31, 2017

DEPRECIATION, SHARE-BASED PAYMENTS, EMPLOYEE AND OTHER EXPENSES

Schedule of depreciation, share-based payments, employee and other expenses

	For the years ended December 31,
	2017		2016		2015
COST OF GOODS SOLD
Depreciation	$	59,115	$	209,613	$	165,884
Share-based payments		70,242		45,803		310,360
Cash-based employee expenses		2,595,654		2,753,841		3,070,566
Other expenses		752,810		4,082,504		3,391,324
	$	3,477,821	$	7,091,761	$	6,938,134
EXPENSES
Selling expenses
Share-based payments	$	98,379	$	138,334	$	120,780
Cash-based employee expenses		202,261		109,150		31,447
Other expenses		585,586		449,154		503,442
		886,226		696,638		655,669
General and administrative expenses
Depreciation		93,196		119,977		78,544
Share-based payments		1,080,627		510,508		1,323,583
Cash-based employee expenses		2,792,897		2,713,110		2,128,392
Litigation expenses		2,410,350		13,170,138		7,058,226
Expenses related to the financing		5,447,182		—		—
Other expenses		3,860,531		2,669,054		3,324,331
		15,684,783		19,182,787		13,913,076
Product development and clinical trials expenses
Depreciation		382,234		426,144		259,281
Share-based payments		1,235,294		1,115,466		2,359,442
Cash-based employee expenses		4,971,668		6,183,013		5,000,258
Other expenses		10,899,896		11,639,880		9,562,414
		17,489,092		19,364,503		17,181,395
TOTAL EXPENSES	$	34,060,101	$	39,243,928	$	31,750,140
Depreciation per Statements of Cash Flows	$	534,545	$	755,734	$	503,709
Share-based payments per Statements of Cash Flows	$	2,484,542	$	1,810,111	$	4,114,165
Cash-based employee expenses (see Note 19)	$	10,562,480	$	11,759,114	$	10,230,663